News - Pharming

Filter

Current filters:

Pharming

Popular Filters

MegaPharm receives marketing and reimbursement approval for Ruconest in Israel

15-01-2014

Privately-owned Israeli pharmaceutical company MegaPharm, partner of Dutch biotech company Pharming Group…

Cardio-vascularMegapharmPharmaceuticalPharmingRegulationRuconest

Pharming and SIPI collaboration includes Ruconest marketing in China

02-07-2013

Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

US FDA accepts Ruconest filing from Santarus and Pharming

18-06-2013

US drugmaker Santarus (Nasdaq: SNTS) and Netherlands-based Pharming Group (NYSE Euronext: PHARM) say…

BiotechnologyCardio-vascularNorth AmericaPharmingRare diseasesRegulationRuconestSantarus

Pharming and Santarus file BLA for Ruconest with US FDA

18-04-2013

Netherlands-based Pharming Group (NYSE Euronext: PHARM) and US licensee Santarus (Nasdaq: SNTS) have…

North AmericaPharmaceuticalPharmingRare diseasesRegulationRuconestSantarus

Pharming gets $10 million milestone from Santarus on Ruconest progress

26-11-2012

Loss-making Dutch biotech company Pharming Group NV (NYSE Euronext: PHARM) said yesterday that, following…

BiotechnologyFinancialPharmingRare diseasesResearchRuconestSantarus

Pharming first-half 2012 net loss nearly doubles

24-08-2012

Netherlands-based biotech company Pharming (NYSE Euronext: PHARM), which recently revealed that it is…

BiotechnologyFinancialPharming

Pharming considers options, including a sale of the company

13-06-2012

Netherland-based biotech company Pharming Group (NYSE Euronext: PHARM) yesterday revealed that it is…

BiotechnologyLicensingMergers & AcquisitionsPharmingRare diseasesResearchRuconest

Pharming in deal with Hyupjin for Ruconest in South Korea

27-03-2012

Dutch biotech firm Pharming Group (NYSE Euronext: PHARM) has entered into an agreement with Seoul-based…

Asia-PacificBiotechnologyHyupjin CorpLicensingPharmingRare diseasesRhucinRuconest

Pharming extends Ruconest deal with SOBI

16-08-2011

Netherlands-based biotech firm Pharming Group NV (Euronext: PHARM) has extended its existing agreement…

BiotechnologyEuropeLicensingPharmaceuticalPharmingRare diseasesRest of the WorldRhucinRuconestSwedish Orphan Biovitrum

Pharming’s Ruconest efficacy backed in new trial

24-05-2011

Netherlands-based biotechnology firm Pharming Group (NYSE Euronext: PHARM) says that new clinical data…

BiotechnologyPharmingRare diseasesResearchRhucinRuconest

Back to top